Evidence map›Paper›PMID 40884664›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Multifocal Genomic Reconstruction Leading to Germline Structural Variants.

Atsushi Hattori, Maki Fukami

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Atsushi HattoriDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Maki FukamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Usually, the human genome acquires one or fewer de novo genomic structural variants (SVs) per generation. However, in rare cases, multiple de novo SVs occur independently on different chromosomes. Typical examples are multiple de novo copy number variants (MdnCNVs) and multifocal genomic crises, collectively termed "multifocal genomic reconstruction." MdnCNVs are characterized by multiple copy number gains on different chromosomes, which can be ascribed to replication-based errors. MdnCNV phenomenon is thought to persist during oogenesis and shortly after fertilization because of maternal factors that predispose oocytes and early embryos to genomic instability. In contrast, multifocal genomic crises result in various SVs such as deletions, duplications, inversions, and chromothriptic SVs, which are likely to be facilitated by replication-based errors and erroneous non-homologous repairs. Multifocal genomic crises appear to be restricted to spermatogenesis and may be influenced by several factors, such as paternal age, genetic background, and environmental exposures. Molecular methods useful for identifying multifocal genomic reconstruction include G-banding, multicolor fluorescence in situ hybridization, chromosomal microarray analysis, short- and long-read next-generation sequencing, and optical genome mapping. These analyses can identify undiscovered cases and lead to a better understanding of the basis of multifocal genomic reconstruction.

Indexed as

Genome, HumanGenomicsGenomic Structural VariationGerm CellsChromosome MappingDNA Copy Number VariationsFemaleHigh-Throughput Nucleotide SequencingHumansIn Situ Hybridization, FluorescenceMaleChromothripsisComplex chromosomal rearrangementCopy number variantHaplotype phasingMultifocal genomic crisisMultiple de novo copy number variantStructural variant

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.